Pricing Log in Create free account
Saturday 17 October 2026 Export ILMN’s income statement to Excel — free account

Illumina, Inc.

ILMN Healthcare Diagnostics & Research

Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024. In the quarter to June 2026, revenue grew 9.44%, EPS fell 8.05%, free cash flow fell 18.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

262.03 5.90 −2.20%
Market cap
$40.5B
P/E
48.4×
Fwd P/E
34.7×
Dividend yield
—
F-score
8/9
Altman Z
4.39
Beneish M
−2.51
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Illumina, Inc. (ILMN) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Illumina, Inc. (ILMN) trades at a P/S ratio of 8.8×. Over the past ten years it has ranged from 2.6× (April 2025) to 22.3× (February 2021); the current reading is higher than 40% of that period. That is above the Diagnostics & Research industry median of 4.4× and above the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 4.7× (3.68%)
FY2024 4.9× 3.49%
FY2023 4.7× (29.83%)
FY2022 6.7× (45.44%)
FY2021 12.3× (24.91%)
FY2020 16.3× 22.00%
FY2019 13.4× 4.05%
FY2018 12.9× 11.30%
FY2017 11.6× 47.86%
FY2016 7.8× (35.88%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 5.9× 37.65%
Mar 2026 4.3× (8.29%)
Dec 2025 4.7× 38.14%
Sep 2025 3.4× (3.09%)
42 more quarters

Against its own ten years

Low 2.6× High 22.3×
Ten-year median 10.4×
Current reading's percentile 44

P/S ratio against peers

Company P/S ratio
LH Labcorp Holdings Inc. compare 1.8×
DGX Quest Diagnostics Incorporated compare 2.3×
IQV IQVIA Holdings Inc. compare 2.6×
A Agilent Technologies, Inc. compare 6.6×
MTD Mettler-Toledo International, Inc. compare 7.9×
ILMN Illumina, Inc. 8.8×
WAT Waters Corporation compare 9.2×
IDXX IDEXX Laboratories, Inc. compare 9.7×
NTRA Natera, Inc. compare 20.7×
Diagnostics & Research industry median 4.4×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on ILMN